Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Mar;49(3):873-83.
doi: 10.1128/AAC.49.3.873-883.2005.

Human cytomegalovirus resistance to antiviral drugs

C Gilbert  1 , G Boivin
Affiliations
Review

Human cytomegalovirus resistance to antiviral drugs

C Gilbert et al. Antimicrob Agents Chemother. 2005 Mar.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Mechanisms of action of systemic antivirals approved for treatment of CMV infections. GCV and CDV, once phosphorylated, compete with dNTPs for the binding site on the DNA pol (A) and are incorporated into HCMV DNA (B), thus inhibiting viral DNA replication. FOS directly inhibits viral DNA replication by blocking the pyrophosphate (ppi) binding site (C), thus preventing ppi cleavage from incoming dNTPs and subsequent incorporation of the nucleotide into viral DNA. MP, DP, and TP, monophosphate, diphosphate, and triphosphate, respectively.
FIG. 2.
FIG. 2.
HCMV UL97 mutations conferring GCV resistance. HCMV UL97 conserved regions are represented by shaded boxes. The numbers under the boxes indicate the positions (codon numbers) of these conserved regions (58). Vertical bars indicate the presence of amino acid substitutions, while the hatched box indicates a region (codons 590 to 607) in which diverse codon deletions (from 1 to 17 codons) have been reported. Other mutations potentially associated with GCV resistance have been described at codons 466 and 521, but no susceptibility testing results were available (20, 44). *, the position of the UL97 mutation (codon 397) involved in maribavir (1263W94) resistance (14).
FIG. 3.
FIG. 3.
HCMV DNA polymerase (UL54) mutations conferring resistance to antivirals. HCMV DNA pol conserved regions are represented by shaded boxes. Numbers under and over the boxes indicate the positions (codon numbers) of these conserved regions (9, 16, 78, 115, 138). Vertical bars indicate the positions of mutations that have been associated with drug resistance. Other mutations (at codons 304, 393, 406, 521, 691, 695, 737, 751, 830, 834, 841, 961, and 972) potentially associated with drug resistance have been reported, but the presence in the same isolate of other known UL54 resistance mutations or the lack of phenotypic evaluation have precluded the ability to make an association with drug resistance (23, 26, 44, 49, 75, 112, 116). Note that resistant strains containing reported mutations were not necessarily tested for all antivirals listed. Dashed lines indicate that independent marker transfer experiments (codons 781 and 802) or substitutions by different amino acids (codon 756) have resulted in discrepant results.
See this image and copyright information in PMC

References

    1. Baldanti, F., D. Lilleri, G. Campanini, G. Comolli, A. L. Ridolfo, S. Rusconi, and G. Gerna. 2004. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response. J. Antimicrob. Chemother. 53:536-539. - PubMed
    1. Baldanti, F., D. Michel, L. Simoncini, M. Heuschmid, A. Zimmermann, R. Minisini, P. Schaarschmidt, T. Schmid, G. Gerna, and T. Mertens. 2002. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antivir. Res. 54:59-67. - PubMed
    1. Baldanti, F., S. Paolucci, A. Parisi, L. Meroni, and G. Gerna. 2002. Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy. Clin. Infect. Dis. 34:1146-1149. - PubMed
    1. Baldanti, F., E. Silini, A. Sarasini, C. L. Talarico, S. C. Stanat, K. K. Biron, M. Furione, F. Bono, G. Palu, and G. Gerna. 1995. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J. Virol. 69:796-800. - PMC - PubMed
    1. Baldanti, F., M. R. Underwood, S. C. Stanat, K. K. Biron, S. Chou, A. Sarasini, E. Silini, and G. Gerna. 1996. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J. Virol. 70:1390-1395. - PMC - PubMed

Substances

LinkOut - more resources